XML 92 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents, And Marketable Securities
6 Months Ended
Jun. 30, 2013
Cash, Cash Equivalents And Marketable Securities [Abstract]  
Cash, Cash Equivalents, And Marketable Securities
Cash, Cash Equivalents, and Marketable Securities
The following table summarizes the Company’s cash, cash equivalents, and marketable securities:
 
 
June 30,
 
December 31,
 
2013
 
2012
 
(In thousands)
Cash
$
57,187

 
$
63,578

Money market funds
92,932

 
38,054

Time deposits
3,919

 
3,614

Debt securities issued by the U.S. Treasury and other U.S. government corporations and agencies
1,851,154

 
1,452,358

Equity securities of a public company

 
3,341

Total
$
2,005,192

 
$
1,560,945

 
 
 
 
Included in Cash and cash equivalents
$
578,301

 
$
130,736

Included in Marketable securities
$
1,419,161

 
$
1,425,700

Included in Other long-term assets (Restricted cash)
$
7,730

 
$
4,509


The following table presents the contractual maturities of the debt securities held as of June 30, 2013:
 
June 30, 2013
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
 
(In thousands)
Due within one year
$
1,821,654

 
$
137

 
$
(8
)
 
$
1,821,783

Due after one year through three years
29,439

 
24

 
(92
)
 
29,371

Total
$
1,851,093

 
$
161

 
$
(100
)
 
$
1,851,154


The unrealized losses as of June 30, 2013 relate to $158.7 million of debt securities issued by the U.S. Treasury and other U.S. government corporations and agencies that have been in a continuous unrealized loss position for less than twelve months. The Company anticipates that it will recover the entire amortized cost basis of these debt securities and has determined that no other-than-temporary impairments were required to be recognized during the six months ended June 30, 2013. The company does not have the intent to sell any of these investments and it is more likely than not that it will not be required to sell any of these investments before recovery of the entire amortized cost basis.